GGrantIndex
← Search

Molecular Analysis of Hotspots of Genetic Recombination

$662,802R01FY2015GMNIH

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators

Linked publications & trials

Abstract

DESCRIPTION (provided by applicant): The long-term goal of the proposed research is to determine the molecular mechanism of homologous genetic recombination and DNA break repair. This goal is approached by studying hotspots of recombination, which stimulate a critical, rate-limiting step of recombination. In the bacterium Escherichia coli, studies will focus on Chi hotspots, which stimulate the major (RecBCD) pathway of recombination and DNA break repair. In the fission yeast Schizosaccharomyces pombe, studies will focus on mutationally created hotspots in the ade6 gene and naturally occurring hotspots across the entire genome. These microbes are especially amenable for genetic and biochemical analyses, but in many ways their recombination mimics that of humans. The specific aims are 1) to elucidate the complex interaction of Chi hotspots and RecBCD enzyme, with special emphasis on testing specific hypotheses of RecBCD's conformational change at Chi which we have recently demonstrated, and 2) to elucidate the determinants of hotspots of meiotic DSB formation across the S. pombe genome, with special emphasis on the interaction of hotspots and their evolution. These aims will be achieved by a combination of biochemistry and electron microscopy with purified components, and genetics, DNA analysis, and fluorescence microscopy with intact cells. The results of these studies will elucidate both the mechanism of recombination and its regulation along chromosomes and during the organism's life cycle. Recombination is important in the faithful repair of DSBs in chromosomes and in the faithful segregation of chromosomes during meiosis. Aberrancies of recombination and DNA break repair are responsible for chromosomal aberrations that are associated with and apparent causes of cancer, birth defects, and certain hereditary diseases. RecBCD and closely related enzymes are widely distributed among bacteria but not eukaryotes and may therefore be good targets for a new class of critically needed antibiotics. Thus, the basic research proposed here will add to the foundations for understanding, diagnosing, preventing, and curing human disease.

View original record on NIH RePORTER →